Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
orbimed
5
×
biotech
san francisco blog main
cancer
medical device
national top stories
new york blog main
san diego
san diego blog main
san diego top stories
venture capital
avalon ventures
boston blog main
clinical trials
correlation ventures
deals
innovation
laura shawver
medicxi
multiple myeloma
ra capital management
raleigh-durham blog main
raleigh-durham top stories
rare disease drugs
san francisco top stories
startups
synthorx
vc
8vc
abbott
abbvie
acqmap
actavalon
acute migrane
acute myeloid leukemia
acutus
advent venture partners
aileron therapeutics
What
company
ipo
advance
biology
cytokine
drug
drugs
enhanced
files
public
san
suite
synthetic
synthorx
activity
acutus
adds
biologic
biotech
blood
broader
cancer
companies
days
demonstrating
detect
developing
diego’s
doctors
dog
electrophysiology
firm
firms
gen
grail
hasn’t
heart
help
high
images
Language
unset
Current search:
orbimed
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
4 years ago
Acutus, Maker of Next-Gen Electrophysiology Tech, Adds $100M Series D
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs